Lanean...
Management of Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
The majority of breast cancers are diagnosed at an early stage and are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative. Significant advances have been made in the management of early stage HR-positive, HER2-negative breast cancer, resulting in improved sur...
Gorde:
| Argitaratua izan da: | Semin Oncol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7374796/ https://ncbi.nlm.nih.gov/pubmed/32546323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2020.05.010 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|